Pacira BioSciences, Inc. has announced the issuance of inducement awards to 19 new employees under its Amended and Restated 2014 Inducement Plan. Approved by the People & Compensation Committee of the Board of Directors, these awards, granted on June 3, 2025, include stock options and restricted stock units. Eleven employees received stock options for a total of 26,700 shares of Pacira common stock, with a 10-year term and a four-year vesting schedule. The remaining 19 employees were granted restricted stock units for an aggregate of 41,600 shares, vesting annually over four years. The stock options are priced at $26.40 per share, based on the closing trading price on the grant date. The vesting of these awards is contingent on continued employment with Pacira.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.